JP2021525875A5 - - Google Patents

Info

Publication number
JP2021525875A5
JP2021525875A5 JP2020567093A JP2020567093A JP2021525875A5 JP 2021525875 A5 JP2021525875 A5 JP 2021525875A5 JP 2020567093 A JP2020567093 A JP 2020567093A JP 2020567093 A JP2020567093 A JP 2020567093A JP 2021525875 A5 JP2021525875 A5 JP 2021525875A5
Authority
JP
Japan
Prior art keywords
carbon atoms
fewer
alkyl
fewer carbon
heteroarylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020567093A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021525875A (ja
JP7381500B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/034977 external-priority patent/WO2019232422A1/en
Publication of JP2021525875A publication Critical patent/JP2021525875A/ja
Publication of JP2021525875A5 publication Critical patent/JP2021525875A5/ja
Priority to JP2023188467A priority Critical patent/JP7583895B2/ja
Application granted granted Critical
Publication of JP7381500B2 publication Critical patent/JP7381500B2/ja
Priority to JP2024192794A priority patent/JP2025016675A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020567093A 2018-05-31 2019-05-31 外傷性脳損傷を検出するための組成物および方法 Active JP7381500B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023188467A JP7583895B2 (ja) 2018-05-31 2023-11-02 外傷性脳損傷を検出するための組成物および方法
JP2024192794A JP2025016675A (ja) 2018-05-31 2024-11-01 外傷性脳損傷を検出するための組成物および方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862678900P 2018-05-31 2018-05-31
US62/678,900 2018-05-31
US201862733025P 2018-09-18 2018-09-18
US62/733,025 2018-09-18
PCT/US2019/034977 WO2019232422A1 (en) 2018-05-31 2019-05-31 Compositions and methods for detection of traumatic brain injury

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023188467A Division JP7583895B2 (ja) 2018-05-31 2023-11-02 外傷性脳損傷を検出するための組成物および方法

Publications (3)

Publication Number Publication Date
JP2021525875A JP2021525875A (ja) 2021-09-27
JP2021525875A5 true JP2021525875A5 (https=) 2022-05-17
JP7381500B2 JP7381500B2 (ja) 2023-11-15

Family

ID=68697319

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020567093A Active JP7381500B2 (ja) 2018-05-31 2019-05-31 外傷性脳損傷を検出するための組成物および方法
JP2023188467A Active JP7583895B2 (ja) 2018-05-31 2023-11-02 外傷性脳損傷を検出するための組成物および方法
JP2024192794A Pending JP2025016675A (ja) 2018-05-31 2024-11-01 外傷性脳損傷を検出するための組成物および方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023188467A Active JP7583895B2 (ja) 2018-05-31 2023-11-02 外傷性脳損傷を検出するための組成物および方法
JP2024192794A Pending JP2025016675A (ja) 2018-05-31 2024-11-01 外傷性脳損傷を検出するための組成物および方法

Country Status (8)

Country Link
US (1) US12478693B2 (https=)
EP (1) EP3803416A4 (https=)
JP (3) JP7381500B2 (https=)
CN (2) CN112424606B9 (https=)
AU (1) AU2019279001B2 (https=)
CA (1) CA3100700A1 (https=)
MA (1) MA52796A (https=)
WO (1) WO2019232422A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019372432B2 (en) * 2018-11-02 2025-05-29 Amydis, Inc. Phosphate compounds for detecting neurological disorders
AU2020348382A1 (en) * 2019-09-18 2022-04-28 Amydis, Inc. Methods of detecting neurological disorders via binding to phosphorylated tau protein
JP2024525693A (ja) * 2021-07-15 2024-07-12 アミディス, インコーポレイテッド 神経変性障害の診断のためにアミロイドおよびアミロイド様タンパク質を検出するためのフルオロフォアとしてのn-ヘテロシクリル置換2-シアノ-3-(ナフタレン-2-イル)アクリルアミド誘導体
WO2024155678A1 (en) * 2023-01-18 2024-07-25 Amydis, Inc. Amyloid targeting agents

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043013A (en) 1987-12-30 1991-08-27 Milliken Research Corporation Washable ink compositions
US5177064A (en) 1990-07-13 1993-01-05 University Of Florida Targeted drug delivery via phosphonate derivatives
US6541454B1 (en) 1995-04-04 2003-04-01 Yissum Research Development Company Of The Hebrew University Jerusalem Phosphonates, biphosphonates and pharmaceutical compositions containing them
US6048662A (en) 1998-12-15 2000-04-11 Bruhnke; John D. Antireflective coatings comprising poly(oxyalkylene) colorants
DE10047237A1 (de) 2000-09-23 2002-04-11 Physoptics Opto Electronic Gmb System zur Aufnahme des Netzhautreflexbildes
JPWO2003020690A1 (ja) 2001-08-29 2004-12-16 協和醗酵工業株式会社 アリールスルファマート誘導体
JP2007504283A (ja) 2003-05-20 2007-03-01 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア β−アミロイド斑に作用物質を結合させる方法
CN101103018A (zh) * 2004-11-16 2008-01-09 神经化学(国际)有限公司 治疗cns和淀粉样蛋白-相关疾病的化合物
ATE525664T1 (de) 2004-11-22 2011-10-15 Abbott Medical Optics Inc Copolymerisierbare methin- und anthrachinon- verbindungen und artikel damit
JP2009184924A (ja) 2006-05-31 2009-08-20 Eisai R & D Management Co Ltd 生物学的試薬用化合物
JP2008013446A (ja) 2006-07-03 2008-01-24 Neugen Pharma:Kk 酸化ストレスによる細胞変性を分子背景とする難治性疾患の治療または予防剤
EP2046322A4 (en) 2006-08-02 2010-10-06 Univ Temple ARYL-VINYL-SULFIDE, -SULFONE, -SULFOXIDE AND -SULFONAMIDES, DERIVATIVES THEREOF AND THERAPEUTIC APPLICATIONS THEREOF
WO2009086303A2 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
EP3231804B1 (en) 2008-03-21 2021-03-03 The General Hospital Corporation Compounds and compositions for the detection and treatment of alzheimer's disease and related disorders
JP5771525B2 (ja) 2008-09-18 2015-09-02 セダーズ−シナイ メディカル センター アルツハイマー病を検出するための光学的方法
US20120282169A1 (en) 2009-11-06 2012-11-08 Adlyfe, Inc. Detection and treatment of traumatic brain injury
SI2509940T1 (sl) 2009-12-10 2015-09-30 The Regents Of The University Of California Sredstva za vezavo amiloida
CN102115429B (zh) 2010-01-06 2013-02-27 中国科学院上海药物研究所 (e)-1-(3,5-二甲氧基苯基)-2-(3,5-二羟基-4-甲氧基苯基)乙烯及其制备方法和用途
KR101194337B1 (ko) 2010-07-14 2012-10-24 웅진코웨이주식회사 레티노이드 유도체 및 그를 포함하는 화장료 조성물
CA2807683C (en) 2010-08-16 2020-02-18 Cognoptix, Inc. System and method for detecting amyloid proteins
CA2814198A1 (en) 2010-10-25 2012-05-10 Steven Verdooner Apparatus and method for detecting amyloid in a retina in a diagnosis, advancement, and prognosing of alzheimer's disease, traumatic brain injury, macular degeneration and a plurality of neurodegenerative dissorders, and ocular diseases
RU2627694C2 (ru) 2010-10-29 2017-08-10 Клино Лтд. Производные хинолина, визуализирующий белок тау
US9588129B2 (en) 2013-03-15 2017-03-07 Amira Medical Technologies Inc. Methods for analyzing blood to detect diseases associated with abnormal protein aggregation
EP3068388A4 (en) 2013-11-11 2017-04-12 Board of Regents of the University of Texas System Neuroprotective compounds and use thereof
EP3068283A1 (en) 2013-11-12 2016-09-21 Cognoptix, Inc. Method for measuring fluorescence in ocular tissue
AU2015231239B2 (en) 2014-03-19 2018-11-29 Amydis, Inc. Amyloid targeting agents and methods of using the same
US9605315B2 (en) * 2014-03-26 2017-03-28 The University Of Montana Detection of traumatic brain injury
WO2015188142A1 (en) 2014-06-05 2015-12-10 Cedars-Sinai Medical Center Diagnosis and monitoring of traumatic brain injury by imaging retinal abnormalities
WO2016040891A2 (en) 2014-09-12 2016-03-17 Amydis Diagnostics In vitro compositions comprising human sample and amyloid targeting agent
WO2016055148A2 (en) 2014-10-06 2016-04-14 Université De Genève Markers and their use in brain injury
WO2017004560A1 (en) * 2015-07-02 2017-01-05 The Regents Of The University Of California Methods and compositions for amyloid aggregates
GB201603967D0 (en) 2016-03-08 2016-04-20 Univ Birmingham Biomarkers of traumatic brain injury
JP7029718B2 (ja) 2017-07-31 2022-03-04 国立研究開発法人量子科学技術研究開発機構 リン酸化タウタンパク質の測定方法
AU2019372432B2 (en) * 2018-11-02 2025-05-29 Amydis, Inc. Phosphate compounds for detecting neurological disorders
AU2020348382A1 (en) 2019-09-18 2022-04-28 Amydis, Inc. Methods of detecting neurological disorders via binding to phosphorylated tau protein
IL305647A (en) 2021-03-12 2023-11-01 Amydis Inc Methods for the detection of systemic amyloidosis by binding to misfolded protein or aggregates
JP2024525693A (ja) 2021-07-15 2024-07-12 アミディス, インコーポレイテッド 神経変性障害の診断のためにアミロイドおよびアミロイド様タンパク質を検出するためのフルオロフォアとしてのn-ヘテロシクリル置換2-シアノ-3-(ナフタレン-2-イル)アクリルアミド誘導体
WO2024155678A1 (en) 2023-01-18 2024-07-25 Amydis, Inc. Amyloid targeting agents

Similar Documents

Publication Publication Date Title
JP2021525875A5 (https=)
US11160880B2 (en) Compositions and methods for assessing eye vasculature
JP5806342B2 (ja) ウイルス成分に結合させた蛍光染料を含む神経画像化用の画像化方法および組成物
CN103874512B (zh) 选择性递送分子及使用方法
JP2020502130A5 (https=)
JP2020511501A5 (https=)
AU2013303233B2 (en) Prostate specific antigen agents and methods of using same for prostate cancer imaging
JP2003520215A5 (https=)
US20110236310A1 (en) Labeling composition for intraocular tissue, labeling method of intraocular tissue, and screening method
JP2015532641A5 (https=)
RU2003137593A (ru) Соединения на основе пептидов для направленной доставки к рецепторам интегринов
JP2003520868A5 (https=)
JP2005519977A (ja) 近赤外蛍光造影剤および蛍光造影法
JP2013540114A5 (https=)
JP2003520288A5 (https=)
DK1937676T3 (en) Biocompatible fluorescent imaging compounds
CN102770460A (zh) 新吲哚菁化合物、其合成法及其精制法、使用该吲哚菁化合物的诊断用组合物、使用该诊断用组合物的生物体内动态测定装置以及循环可视化装置
CN104245954A (zh) 细菌成像剂及其使用方法
CA3179937A1 (en) Phthalocyanine dye compounds, conjugates and methods of use thereof
RU2016147398A (ru) Способы оценивания и лечения острого миелоидного лейкоза
JP2022548158A5 (https=)
JP2010195764A (ja) 新規化合物、該新規化合物を用いたプローブ及び該新規化合物もしくは該プローブを用いた蛍光イメージング用造影剤
JP2018511556A5 (https=)
JP2021525875A (ja) 外傷性脳損傷を検出するための組成物および方法
JP2020513050A5 (https=)